Article
Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 Aug 2008
Hare C Bradley, Mellors John, Krambrink Amy, Su Zhaohui, Skiest Daniel, Margolis David M, Patel Sheran S, Barnas Douglas, Frenkel Lisa, Coombs Robert W, Aweeka Francesca, Morse Gene D, Haas David W, Boltz Valerie, Palmer Sarah, Coffin John, Havlir Diane V
Abstract excerpt
Using standard and ultrasensitive techniques, we detected nonnucleoside reverse-transcriptase inhibitor-associated resistance mutations in 11 (20%) of 54 subjects who discontinued virologically suppressive nonnucleoside reverse-transcriptase inhibitor-containing antiretroviral therapy. Resistance was detected in 45% and 14% of subjects with a baseline human immunodeficiency virus type 1 RNA level of 51-400...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
